Depression of contact sensitivity to oxazolone by the paramyxovirus of Newcastle disease. Impairment by infectious virus of effector T cells which mediate the response to contactant. 1981

C Caruso, and P Palmeri, and F Dieli, and L Bellina, and S Benvegna, and E Cillari, and A Salerno

The paramyxovirus of Newcastle disease (NDV) impairs the contact sensitivity to oxazolone in CBA/J mice: in vitro treatment with the infectious virus inhibits the passive transfer of contact sensitivity. Experiments performed with three different virus preparations demonstrate that only the infectious virus is able to inhibit the hypersensitivity reaction while treatment of virus by heat or ultraviolet irradiation wipes out its inhibitory activity. These results suggest that I-NDV depresses the response to oxazolone by its action on T immunoblasts which mediate the response to contactant.

UI MeSH Term Description Entries
D006968 Hypersensitivity, Delayed An increased reactivity to specific antigens mediated not by antibodies but by sensitized T CELLS. Hypersensitivity, Tuberculin-Type,Hypersensitivity, Type IV,Tuberculin-Type Hypersensitivity,Type IV Hypersensitivity,Delayed Hypersensitivity,Delayed Hypersensitivities,Hypersensitivity, Tuberculin Type,Tuberculin Type Hypersensitivity,Tuberculin-Type Hypersensitivities,Type IV Hypersensitivities
D007116 Immunization, Passive Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER). Convalescent Plasma Therapy,Immunoglobulin Therapy,Immunotherapy, Passive,Normal Serum Globulin Therapy,Passive Antibody Transfer,Passive Transfer of Immunity,Serotherapy,Passive Immunotherapy,Therapy, Immunoglobulin,Antibody Transfer, Passive,Passive Immunization,Therapy, Convalescent Plasma,Transfer, Passive Antibody
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D008808 Mice, Inbred CBA An inbred strain of mouse that is widely used in BIOMEDICAL RESEARCH. Mice, CBA,Mouse, CBA,Mouse, Inbred CBA,CBA Mice,CBA Mice, Inbred,CBA Mouse,CBA Mouse, Inbred,Inbred CBA Mice,Inbred CBA Mouse
D009521 Newcastle Disease An acute febrile, contagious, viral disease of birds caused by an AVULAVIRUS called NEWCASTLE DISEASE VIRUS. It is characterized by respiratory and nervous symptoms in fowl and is transmissible to man causing a severe, but transient conjunctivitis. Disease, Newcastle
D010080 Oxazoles Five-membered heterocyclic ring structures containing an oxygen in the 1-position and a nitrogen in the 3-position, in distinction from ISOXAZOLES where they are at the 1,2 positions. Oxazole,1,3-Oxazolium-5-Oxides,Munchnones,1,3 Oxazolium 5 Oxides
D010081 Oxazolone Immunologic adjuvant and sensitizing agent. 2-Phenyl-4-(ethoxymethylene)oxazol-5-one,4-Ethoxymethylene-2-phenyloxazolone,4 Ethoxymethylene 2 phenyloxazolone
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell

Related Publications

C Caruso, and P Palmeri, and F Dieli, and L Bellina, and S Benvegna, and E Cillari, and A Salerno
January 1979, International archives of allergy and applied immunology,
C Caruso, and P Palmeri, and F Dieli, and L Bellina, and S Benvegna, and E Cillari, and A Salerno
August 1985, Cellular immunology,
C Caruso, and P Palmeri, and F Dieli, and L Bellina, and S Benvegna, and E Cillari, and A Salerno
February 1984, Immunology,
C Caruso, and P Palmeri, and F Dieli, and L Bellina, and S Benvegna, and E Cillari, and A Salerno
January 1982, International archives of allergy and applied immunology,
C Caruso, and P Palmeri, and F Dieli, and L Bellina, and S Benvegna, and E Cillari, and A Salerno
March 1972, Veterinariia,
C Caruso, and P Palmeri, and F Dieli, and L Bellina, and S Benvegna, and E Cillari, and A Salerno
April 2009, International journal of oncology,
C Caruso, and P Palmeri, and F Dieli, and L Bellina, and S Benvegna, and E Cillari, and A Salerno
February 1988, Cellular immunology,
C Caruso, and P Palmeri, and F Dieli, and L Bellina, and S Benvegna, and E Cillari, and A Salerno
January 1987, International journal of immunopharmacology,
C Caruso, and P Palmeri, and F Dieli, and L Bellina, and S Benvegna, and E Cillari, and A Salerno
January 1991, International archives of allergy and applied immunology,
C Caruso, and P Palmeri, and F Dieli, and L Bellina, and S Benvegna, and E Cillari, and A Salerno
October 1990, The Journal of investigative dermatology,
Copied contents to your clipboard!